2025-08-08 – Press Releases – www.prnewswire.com
YANTAI, China, Aug. 8, 2025 /PRNewswire/ — On August 8th, RemeGen Co., Ltd. (688331.SH/09995.HK) announces clearance of IND application by Food and Drug Administration (FDA) for phase II clinical trials for its independently-developed bispecific antibody, RC148, for the treatment of…
